Compounds > 3,3',4'-trihydroxyflavone
Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin

3,3',4'-trihydroxyflavone has been researched along with mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin in 1 studies

Compound Research Comparison

Studies
(3,3',4'-trihydroxyflavone)		Trials
(3,3',4'-trihydroxyflavone)		Recent Studies (post-2010)
(3,3',4'-trihydroxyflavone)		Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)		Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
3902269042

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hart, JL; Leo, CH; Woodman, OL1

Other Studies

1 other study(ies) available for 3,3',4'-trihydroxyflavone and mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin

ArticleYear
3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes.
    European journal of pharmacology, 2011, Jun-01, Volume: 659, Issue:2-3

    Topics: Animals; Antioxidants; Biomimetic Materials; Blood Glucose; Body Weight; Cyclic N-Oxides; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Endothelium, Vascular; Flavonols; Mesenteric Arteries; Metalloporphyrins; Microvessels; Rats; Rats, Sprague-Dawley; Spin Labels; Superoxides; Vasodilation

2011